555 related articles for article (PubMed ID: 15592498)
21. IGF-1 activates hEAG K(+) channels through an Akt-dependent signaling pathway in breast cancer cells: role in cell proliferation.
Borowiec AS; Hague F; Harir N; Guénin S; Guerineau F; Gouilleux F; Roudbaraki M; Lassoued K; Ouadid-Ahidouch H
J Cell Physiol; 2007 Sep; 212(3):690-701. PubMed ID: 17520698
[TBL] [Abstract][Full Text] [Related]
22. Antiestrogen-resistant human breast cancer cells require activated protein kinase B/Akt for growth.
Frogne T; Jepsen JS; Larsen SS; Fog CK; Brockdorff BL; Lykkesfeldt AE
Endocr Relat Cancer; 2005 Sep; 12(3):599-614. PubMed ID: 16172194
[TBL] [Abstract][Full Text] [Related]
23. Involvement of Ras activation in human breast cancer cell signaling, invasion, and anoikis.
Eckert LB; Repasky GA; Ulkü AS; McFall A; Zhou H; Sartor CI; Der CJ
Cancer Res; 2004 Jul; 64(13):4585-92. PubMed ID: 15231670
[TBL] [Abstract][Full Text] [Related]
24. Effect of zinc on regulation of insulin-like growth factor signaling in human androgen-independent prostate cancer cells.
Banudevi S; Senthilkumar K; Sharmila G; Arunkumar R; Vijayababu MR; Arunakaran J
Clin Chim Acta; 2010 Feb; 411(3-4):172-8. PubMed ID: 19913001
[TBL] [Abstract][Full Text] [Related]
25. Suppression of Polo like kinase 1 (PLK1) by p21(Waf1) mediates the p53-dependent prevention of caspase-independent mitotic death.
Lin YC; Sun SH; Wang FF
Cell Signal; 2011 Nov; 23(11):1816-23. PubMed ID: 21726628
[TBL] [Abstract][Full Text] [Related]
26. NO donor and MEK inhibitor synergistically inhibit proliferation and invasion of cancer cells.
Furuhashi S; Sugita H; Takamori H; Horino K; Nakahara O; Okabe H; Miyake K; Tanaka H; Beppu T; Baba H
Int J Oncol; 2012 Mar; 40(3):807-15. PubMed ID: 22025280
[TBL] [Abstract][Full Text] [Related]
27. Sensitization of tumor cells to Apo2 ligand/TRAIL-induced apoptosis by inhibition of casein kinase II.
Ravi R; Bedi A
Cancer Res; 2002 Aug; 62(15):4180-5. PubMed ID: 12154014
[TBL] [Abstract][Full Text] [Related]
28. Different roles for caveolin-1 in the development of non-small cell lung cancer versus small cell lung cancer.
Sunaga N; Miyajima K; Suzuki M; Sato M; White MA; Ramirez RD; Shay JW; Gazdar AF; Minna JD
Cancer Res; 2004 Jun; 64(12):4277-85. PubMed ID: 15205342
[TBL] [Abstract][Full Text] [Related]
29. Abrogation of p53 by its antisense in MCF-7 breast carcinoma cells increases cyclin D1 via activation of Akt and promotion of cell proliferation.
Chhipa RR; Kumari R; Upadhyay AK; Bhat MK
Exp Cell Res; 2007 Nov; 313(19):3945-58. PubMed ID: 17935714
[TBL] [Abstract][Full Text] [Related]
30. Neu differentiation factor (Heregulin) activates a p53-dependent pathway in cancer cells.
Bacus SS; Yarden Y; Oren M; Chin DM; Lyass L; Zelnick CR; Kazarov A; Toyofuku W; Gray-Bablin J; Beerli RR; Hynes NE; Nikiforov M; Haffner R; Gudkov A; Keyomarsi K
Oncogene; 1996 Jun; 12(12):2535-47. PubMed ID: 8700512
[TBL] [Abstract][Full Text] [Related]
31. CCAAT/Enhancer binding protein delta (c/EBPdelta) regulation and expression in human mammary epithelial cells: I. "Loss of function" alterations in the c/EBPdelta growth inhibitory pathway in breast cancer cell lines.
Sivko GS; DeWille JW
J Cell Biochem; 2004 Nov; 93(4):830-43. PubMed ID: 15389879
[TBL] [Abstract][Full Text] [Related]
32. The role of growth factor receptor pathways in human breast cancer cells adapted to long-term estrogen deprivation.
Sabnis GJ; Jelovac D; Long B; Brodie A
Cancer Res; 2005 May; 65(9):3903-10. PubMed ID: 15867390
[TBL] [Abstract][Full Text] [Related]
33. Caveolin-1 Confers Resistance of Hepatoma Cells to Anoikis by Activating IGF-1 Pathway.
Tang W; Feng X; Zhang S; Ren Z; Liu Y; Yang B; lv B; Cai Y; Xia J; Ge N
Cell Physiol Biochem; 2015; 36(3):1223-36. PubMed ID: 26138883
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of the biologic response to insulin-like growth factor I in MCF-7 breast cancer cells by a new monoclonal antibody to the insulin-like growth factor-I receptor. The importance of receptor down-regulation.
Jackson-Booth PG; Terry C; Lackey B; Lopaczynska M; Nissley P
Horm Metab Res; 2003; 35(11-12):850-6. PubMed ID: 14710368
[TBL] [Abstract][Full Text] [Related]
35. Expression of ErbB2 enhances radiation-induced NF-kappaB activation.
Guo G; Wang T; Gao Q; Tamae D; Wong P; Chen T; Chen WC; Shively JE; Wong JY; Li JJ
Oncogene; 2004 Jan; 23(2):535-45. PubMed ID: 14724581
[TBL] [Abstract][Full Text] [Related]
36. IL-1beta suppresses prolonged Akt activation and expression of E2F-1 and cyclin A in breast cancer cells.
Shen WH; Jackson ST; Broussard SR; McCusker RH; Strle K; Freund GG; Johnson RW; Dantzer R; Kelley KW
J Immunol; 2004 Jun; 172(12):7272-81. PubMed ID: 15187102
[TBL] [Abstract][Full Text] [Related]
37. Cardiac stem cell and myocyte aging, heart failure, and insulin-like growth factor-1 overexpression.
Torella D; Rota M; Nurzynska D; Musso E; Monsen A; Shiraishi I; Zias E; Walsh K; Rosenzweig A; Sussman MA; Urbanek K; Nadal-Ginard B; Kajstura J; Anversa P; Leri A
Circ Res; 2004 Mar; 94(4):514-24. PubMed ID: 14726476
[TBL] [Abstract][Full Text] [Related]
38. DNA damage uncouples the mitogenic response to IGF-I in MCF-7 malignant breast cancer cells by switching the roles of PI3 kinase and p21WAF1/Cip1.
Clark MA; Perks CM; Winters ZE; Holly JM
Int J Cancer; 2005 Sep; 116(4):506-13. PubMed ID: 15818613
[TBL] [Abstract][Full Text] [Related]
39. G1/S cell cycle arrest provides anoikis resistance through Erk-mediated Bim suppression.
Collins NL; Reginato MJ; Paulus JK; Sgroi DC; Labaer J; Brugge JS
Mol Cell Biol; 2005 Jun; 25(12):5282-91. PubMed ID: 15923641
[TBL] [Abstract][Full Text] [Related]
40. Receptor synergy of interleukin-6 (IL-6) and insulin-like growth factor-I in myeloma cells that highly express IL-6 receptor alpha [corrected].
Abroun S; Ishikawa H; Tsuyama N; Liu S; Li FJ; Otsuyama K; Zheng X; Obata M; Kawano MM
Blood; 2004 Mar; 103(6):2291-8. PubMed ID: 14592826
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
